| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $95M | ||
| $91M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Over the last 12 months, insiders at Nutriband Inc. have bought $0 and sold $0 worth of Nutriband Inc. stock.
On average, over the past 5 years, insiders at Nutriband Inc. have bought $4,030 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $4,030 was made by MELNIK SERGUEI (Chairman and President) on 2022‑02‑24.
| MELNIK SERGUEI | Chairman and President | 633000 5.2073% | $2.27M | 1 | 0 | +9.14% |
$155,630,608 | 79 | -24.53% | $54.18M | |
$693,326 | 47 | -16.18% | $49.93M | |
$95,303,339 | 30 | -13.78% | $34.69M | |
$2,983,776 | 25 | -16.47% | $33.5M | |
$523,320 | 24 | 94.37% | $34.12M | |
$241,165 | 22 | -16.72% | $33.88M | |
$226,127 | 22 | -27.62% | $48.55M | |
$351,813 | 19 | 21.51% | $32.46M | |
$3,556,951 | 18 | 9.64% | $41.07M | |
$31,610,161 | 9 | -73.83% | $46.07M | |
$189,648 | 9 | -52.20% | $32.31M | |
$208,889 | 5 | 44.22% | $46.08M | |
$104,699 | 5 | -12.61% | $38.49M | |
$5,306,958 | 5 | 11.70% | $44.15M | |
$657,791 | 4 | -52.05% | $37.18M | |
$67,369,250 | 3 | -22.09% | $45.13M | |
Nutriband Inc. (NTRB) | $4,030 | 1 | 9.14% | $43.52M |
$4,999,995 | 1 | -67.50% | $48.99M | |
$150,000 | 1 | 5.48% | $45.8M |
| Increased Positions | 5 | +17.86% | 17,605 | +4.71% |
| Decreased Positions | 9 | -32.14% | 27,180 | -7.27% |
| New Positions | 4 | New | 17,251 | New |
| Sold Out Positions | 3 | Sold Out | 319 | Sold Out |
| Total Postitions | 24 | -14.29% | 364,194 | -2.56% |
| Vanguard Group Inc | $898.00 | 1.69% | 202,738 | +3,111 | +1.56% | 2025-09-30 |
| Geode Capital Management, Llc | $266.00 | 0.5% | 59,943 | -3,688 | -5.8% | 2025-09-30 |
| State Street Corp | $111.00 | 0.21% | 24,966 | 0 | 0% | 2025-09-30 |
| Ubs Group Ag | $87.00 | 0.16% | 19,637 | +19,636 | +1.96M% | 2025-09-30 |
| Cetera Investment Advisers | $84.00 | 0.16% | 18,900 | +18,900 | New | 2025-09-30 |
| Northern Trust Corp | $62.00 | 0.12% | 13,945 | +2,463 | +21.45% | 2025-09-30 |
| Haven Private, Llc | $51.00 | 0.1% | 11,521 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $37.00 | 0.07% | 8,420 | +135 | +1.63% | 2025-09-30 |
| Osaic Holdings, Inc. | $21.00 | 0.04% | 4,851 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $16.00 | 0.03% | 3,500 | 0 | 0% | 2025-09-30 |